
<purchabr>MICROBIO</purchabr> {<purchcode>MRC</purchcode>} PLANS ACQUISITION, FINANCING
    BOUNTIFUL, Utah, March 2 - <purchaser>Microbiological Research Corp</purchaser>
said it entered into a <status>letter of intent</status> for a proposed business
combination with privately owned {<acquired>DataGene Scientific
Laboratories Inc</acquired>}, and {<acquired>Milex Corp</acquired>} a newly formed company,
through a stock swap.
    It also said it received 100,000 dlrs from the sale of a
convertible note to Ventana Growth Fund as part of an overall
1,100,000 equity financing plan with Ventana. Under that plan,
a minimum of 400,000 dlrs and a maximum of one mln dlrs of
additional new capital is to be provided to fund the combined
operations of the three companies.
    <purchabr>Microbiological</purchabr> also said that if the maximum additional
capital is raised, it will own about 49 pct of 4,550,00 shares
of common outstanding in the new combined company, <acqabr>DataGene</acqabr>
holders will own 29 pct, and Ventana and others will own 13
pct.
    It said the remaining nine pct will be held by <acqabr>Milex</acqabr>
shareholder Norman Monson, who will become chief executive
officer of the combined companies.
 Reuter



 